Related Experiment Videos
Muscle involvement in juvenile idiopathic arthritis
1Department of Clinical Neurophysiology, University Hospital, SE-581 85 Linköping, Sweden. hans.lindehammar@lio.se
Rheumatology (Oxford, England)
|September 3, 2004
Summary
Muscle biopsies in juvenile idiopathic arthritis (JIA) often show changes, with reduced muscle strength linked to smaller muscle fibers. Inflammation markers like MHC class II were elevated in JIA patients, suggesting potential inflammatory myopathy.
Area of Science:
- Rheumatology
- Pediatric Rheumatology
- Muscle Biology
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition affecting children and adolescents.
- Understanding the impact of JIA on skeletal muscle structure and function is crucial for effective management.
Purpose of the Study:
- To investigate muscle structural changes and their relationship with muscle strength in children and teenagers diagnosed with JIA.
- To identify potential markers of inflammation within muscle tissue in JIA patients.
Main Methods:
- Observational study involving 15 JIA patients (ages 9-19) and 33 healthy controls.
- Histopathological and immunohistochemical analysis of anterior tibial muscle biopsies, assessing fiber types, areas, and inflammation markers (MHC class I/II, MAC).
- Measurement of ankle dorsiflexion strength (isometric and isokinetic) and nerve conduction velocities.
Main Results:
- Muscle biopsies from JIA patients frequently exhibited unspecific changes, with some showing minor inflammation and elevated MHC class II expression compared to controls.
- A significant reduction in muscle strength was observed in JIA patients, positively correlated with muscle fiber area.
- No evidence of type II muscle fiber hypotrophy or neuropathy was found.
Conclusions:
- Muscle biopsy abnormalities are common in pediatric JIA patients.
- Elevated MHC class II expression suggests a potential inflammatory myopathy component in JIA.
- Unlike adult rheumatoid arthritis, JIA does not appear to involve type II muscle fiber hypotrophy or neuropathy.